Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
Global AI in Healthcare market size was $16.02 Billion in 2022 and it is forecasted to reach $202.37 Billion by 2030. AI in Healthcare Industry's Compound Annual Growth Rate will be 37.34% from 2023 to 2030. Download a free sample with data verified by Aarti Bagekari
| Data Timeline | Historical Data: 2022–2025 | Base Year: 2025 | Forecast Period: 2026–2034 |
|---|---|
| Offering Segment | Solutions, Services |
| Function Segment | Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Clinical Trials, Diagnostics, Others |
| Application Segment | Clinical Operations, Non clinical Operations |
|---|---|
| DEPLOYMENT MODEL Segment | On-premises, On Cloud, Hybrid |
| Technology Segment | Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision, Image Analysis |
| End User Segment | Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Contract Research Organization (CRO), Others |
| Regions & Countries |
|
Country-level data · Company profiles · Editable dataset · Analyst consultation included.
| Region / Country | 2021 (A) | 2025 (A) | 2033 (P) | CAGR |
|---|---|---|---|---|
| Global | $ 10074.2 Million | $ 27571.3 Million | $ 206515 Million | 28.621% |
| North America | $ 5460.21 Million | $ 14764.4 Million | $ 108008 Million | 28.242% |
| United States | $ 4428.23 Million | $ 11923.8 Million | $ 86438.4 Million | 28.096% |
| Canada | $ 611.54 Million | $ 1696.43 Million | $ 13079.7 Million | 29.087% |
| Mexico | $ 420.44 Million | $ 1144.24 Million | $ 8489.39 Million | 28.468% |
| Europe | $ 1773.06 Million | $ 4714.69 Million | $ 33868.5 Million | 27.951% |
| United Kingdom | $ 216.31 Million | $ 584.62 Million | $ 4325.01 Million | 28.422% |
| France | $ 226.24 Million | $ 589.81 Million | $ 4050.67 Million | 27.234% |
| Germany | $ 358.16 Million | $ 971.23 Million | $ 7349.47 Million | 28.785% |
| Italy | $ 188.3 Million | $ 495.04 Million | $ 3468.14 Million | 27.55% |
| Russia | $ 124.11 Million | $ 315.88 Million | $ 2082.91 Million | 26.588% |
| Spain | $ 149.29 Million | $ 401.22 Million | $ 2946.56 Million | 28.304% |
| Sweden | $ 115.6 Million | $ 309.76 Million | $ 2253.95 Million | 28.157% |
| Denmark | $ 65.6 Million | $ 172.09 Million | $ 1205.72 Million | 27.552% |
| Switzerland | $ 83.87 Million | $ 217.82 Million | $ 1486.83 Million | 27.137% |
| Luxembourg | $ 21.28 Million | $ 54.46 Million | $ 360.36 Million | 26.645% |
| Rest of Europe | $ 224.29 Million | $ 602.77 Million | $ 4338.9 Million | 27.983% |
| Asia Pacific | $ 1692.46 Million | $ 4866.33 Million | $ 40270.5 Million | 30.234% |
| China | $ 453.58 Million | $ 1313.91 Million | $ 11054.2 Million | 30.503% |
| Japan | $ 264.02 Million | $ 742.12 Million | $ 5823.11 Million | 29.371% |
| South Korea | $ 196.33 Million | $ 554.28 Million | $ 4425.73 Million | 29.653% |
| India | $ 196.5 Million | $ 586.39 Million | $ 5235.16 Million | 31.475% |
| Australia | $ 118.47 Million | $ 327.99 Million | $ 2533.01 Million | 29.114% |
| Singapore | $ 64.65 Million | $ 187.84 Million | $ 1590.68 Million | 30.609% |
| Taiwan | $ 64.31 Million | $ 180.54 Million | $ 1440.07 Million | 29.636% |
| South East Asia | $ 143.86 Million | $ 422.88 Million | $ 3636.43 Million | 30.86% |
| Rest of APAC | xxxx | xxxx | xxxx | xxxx |
| South America | $ 483.56 Million | $ 1345.48 Million | $ 10371.2 Million | 29.083% |
| Brazil | $ 170.21 Million | $ 470.92 Million | $ 3590.51 Million | 28.907% |
| Argentina | $ 106.38 Million | $ 300.45 Million | $ 2392.64 Million | 29.61% |
| Colombia | $ 66.25 Million | $ 183.98 Million | $ 1359.04 Million | 28.398% |
| Peru | $ 43.52 Million | $ 120.39 Million | $ 915.57 Million | 28.865% |
| Chile | $ 35.3 Million | $ 99.16 Million | $ 780.95 Million | 29.43% |
| Rest of South America | $ 61.9 Million | $ 170.58 Million | $ 1332.49 Million | 29.298% |
| Middle East | $ 362.67 Million | $ 1004.97 Million | $ 7676.17 Million | 28.936% |
| Saudi Arabia | $ 102.27 Million | $ 284.31 Million | $ 2184.64 Million | 29.032% |
| Turkey | $ 60.93 Million | $ 170.75 Million | $ 1341.03 Million | 29.386% |
| UAE | $ 53.82 Million | $ 153.06 Million | $ 1234.33 Million | 29.814% |
| Egypt | $ 48.24 Million | $ 131.75 Million | $ 968.73 Million | 28.323% |
| Qatar | $ 37.07 Million | $ 101.61 Million | $ 762.32 Million | 28.647% |
| Rest of Middle East | $ 60.35 Million | $ 163.5 Million | $ 1185.12 Million | 28.095% |
| Africa | $ 302.23 Million | $ 875.39 Million | $ 6321.43 Million | 28.034% |
| East Africa | xxxx | xxxx | xxxx | xxxx |
| West Africa | xxxx | xxxx | xxxx | xxxx |
| North Africa | xxxx | xxxx | xxxx | xxxx |
| South Africa | $ 124.82 Million | $ 368.19 Million | $ 2776.37 Million | 28.729% |
A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.
Unlock full regional dataset →Offering breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.
Charts are illustrative — exact values, country-level breakdowns, and full forecast in the paid report. Request a Free Sample PDF.
To learn more about market share and segmentation, request the free sample pages.
IBM Corporation is a US-based technology company. The company offers computer hardware, middleware, and software, and provides hosting and consulting services in areas ranging from mainframe computers to nanotechnology.
The company operates through four business segments including software, consulting, infrastructure, and financing. The software segment comprises two business areas as Hybrid Platform & Solutions and Transaction Processing
Its consulting segment provides industry expertise and capabilities in business transformation and technology implementation. Consulting designs and builds open, hybrid cloud architectures and optimizes key workflows and business processes with IBM and ecosystem partner technologies. Consulting comprises three business areas such as business transformation, technology consulting, and application operations.
In March 2024, Microsoft collaborated with NVIDIA to enhance AI innovation and accelerate computing capabilities. This collaboration leverages Microsoft Azure's global scale and advanced computing along with NVIDIA’s DGX Cloud and Clara suite to accelerate innovation and improve patient carehttps://news.microsoft.com/2024/03/18/microsoft-announces-collaboration-with-nvidia-to-accelerate-healthcare-and-life-sciences-innovation-with-advanced-cloud-ai-and-accelerated-computing-capabilities/
| Top Companies (In no particular order) | 2022 (A) | 2023 (A) | 2024 (A) | 2025 (A) |
|---|---|---|---|---|
| Koninklijke Philips N.V. (Netherlands) | ••• | ••• | ••• | ••• |
| Microsoft (US) | ••• | ••• | ••• | ••• |
| Siemens Healthineers AG (Germany) | ••• | ••• | ••• | ••• |
| NVIDIA Corporation (US) | ••• | ••• | ••• | ••• |
| Epic Systems Corporation (US) | ••• | ••• | ••• | ••• |
| GE Healthcare (US) | ••• | ••• | ••• | ••• |
| Medtronic (US) | ••• | ••• | ••• | ••• |
| Oracle (US) | ••• | ••• | ••• | ••• |
| Veradigm LLC (US) | ••• | ••• | ••• | ••• |
| Merative (IBM) (US) | ••• | ••• | ••• | ••• |
| Google (US) | ••• | ••• | ••• | ••• |
| Cognizant (US) | ••• | ••• | ••• | ••• |
We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.
Request company profile for validation →The AI in Healthcare market is poised for exponential growth, transforming the medical landscape. Driven by the proliferation of big data, advancements in machine learning algorithms, and the increasing need for operational efficiency, AI is revolutionizing patient care. Key applications include enhancing diagnostic accuracy, particularly in medical imaging, accelerating drug discovery pipelines, and enabling personalized treatment plans. The technology also plays a crucial role in optimizing hospital workflows, managing electronic health records, and predicting disease outbreaks. While challenges such as data privacy, regulatory hurdles, and high implementation costs persist, the potential benefits are immense. Strategic investments and collaborations between tech companies and healthcare providers are fueling innovation, promising a future of more predictive, preventative, and personalized healthcare for all.
Artificial Intelligence (AI) is increasingly gaining traction in the healthcare industry. This technology has the potential to transform several aspects of patient care along with administrative processes within providers, and pharmaceutical organizations. Health organizations have accumulated a huge amount of data sets in terms of health records and images, claims data, population data, and clinical trial data. In this case, AI technology plays an important role to analyze this data and provide better solutions that humans cannot find on their own. Thus, AI technologies enable healthcare organizations to analyze their assets, data, and resources. It also improves the efficiency and performance of clinical as well as operational processes, workflows, and financial operations.
Furthermore, AI-enabled deep learning technologies, content analytics, Natural Language Processing (NLP), and predictive analytics tools are enabling healthcare practitioners to diagnose patients’ health conditions at an earlier stage. Therefore, AI algorithms are referred to analyze patient health information which further supports physicians in quickly diagnosing the health condition and providing an accurate treatment regime. Moreover, the sudden outbreak of the COVID-19 pandemic has positively affected the market due to the increased shortage of healthcare workforce. Factors such as the growing number of mergers & acquisitions along with technological collaborations among key market players, and positive government initiatives are boosting the AI in Healthcare market and surging the adoption rate of AI in Healthcare.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The AI in Healthcare Market Analysis is witnessing significant growth in the near future.
In 2023, the Solutions segment accounted for a notable share of the AI in Healthcare Market Analysis.
Driven by a passion for transforming complex digital and business data into actionable market intelligence, Aarti Bagekari focuses her research expertise on the Services & Software and Internet & Communication sectors. Her professional interests lie in analyzing evolving technology ecosystems, digital business models, software innovation, communication infrastructure, and emerging trends that are reshaping the global digital economy.
By leveraging a combination of primary and secondary research methodologies, Aarti develops comprehensive market perspectives that enable organizations to make informed strategic decisions in highly dynamic and competitive environments. Her work involves engaging with industry experts, technology providers, service operators, and key stakeholders while conducting extensive analysis of market data, industry developments, regulatory landscapes, and competitive dynamics. This balanced research approach allows her to uncover meaningful market patterns and identify opportunities that support long-term business growth.
Aarti possesses strong capabilities in market sizing and forecasting, competitive benchmarking, customer and stakeholder research, technology trend analysis, and strategic market assessment. She regularly evaluates developments across software solutions, cloud computing, digital services, telecommunications, internet platforms, enterprise technologies, and next-generation communication networks. Her ability to synthesize large volumes of information into clear and actionable insights helps organizations better understand market shifts, customer expectations, and emerging business opportunities.
At Cognitive Market Research & Consulting, Aarti contributes to market research reports, custom consulting engagements, and survey-based studies that support technology vendors, service providers, investors, and enterprise decision-makers. Her analytical mindset, attention to detail, and commitment to research excellence enable clients to navigate rapidly evolving digital markets, strengthen competitive positioning, and develop sustainable growth strategies in an increasingly connected world.
★ Reviews
Rate this report
| Offering | Solutions, Services |
|---|---|
| Function | Robot-Assisted Surgery, Virtual Nursing Assistant, Administrative Workflow Assistance, Clinical Trials, Diagnostics, Others |
| Application | Clinical Operations, Non clinical Operations |
| DEPLOYMENT MODEL | On-premises, On Cloud, Hybrid |
| Technology | Machine Learning, Natural Language Processing, Context-aware Computing, Computer Vision, Image Analysis |
| End User | Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Contract Research Organization (CRO), Others |
| List of Competitors | Koninklijke Philips N.V. (Netherlands), Microsoft (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US) |
Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Aarti Bagekari and team for the AI in Healthcare Market Analysis Market analysis.
Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.
Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.
Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.
Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.
Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.
To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.
The growing datasets of patient health-related digital information, increasing demand for personalized medicine, and the rising demand for reducing care expenses are some of the major driving forces of the market growth.
We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the AI in Healthcare Market Analysis market.
Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the ai in healthcare market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.
Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.
Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.
Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.
